Veracyte
VCYT
55 hedge funds and large institutions have $118M invested in Veracyte in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 7 closing their positions.
109% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 11
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
53% more capital invested
Capital invested by funds: $77.5M → $118M (+$40.9M)
5% less funds holding
Funds holding: 58 → 55 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $529K
Top Buyers
| 1 |
CC
Cannell Capital
Alta,
Wyoming
|
+$2.15M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$1.27M |
| 3 |
Renaissance Technologies
New York
|
+$594K |
| 4 |
BC
Birchview Capital
Burlington,
Vermont
|
+$195K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$184K |
Top Sellers
VCYT Hedge Fund Activity: Q3 2016 in Review
55 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q3 2016, worth a combined $118M — up 53% from $77.5M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of VCYT and 4 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 23 added.
The largest buyer was Cannell Capital, opening a new position worth an estimated $2.15M. The largest seller was Clough Capital Partners, exiting entirely with an estimated $1.35M sold.
- 55 institutional investors held Veracyte (VCYT) as of Q3 2016, down from 58 in Q2 2016.
- Funds reported $118M of Veracyte stock for Q3 2016, up 53% quarter-over-quarter.
- 4 funds opened new Veracyte positions in Q3 2016 and 7 closed out, a net change of -3 holders.
- The largest Veracyte buyer in Q3 2016 was Cannell Capital, an estimated $2.15M added.
- The largest Veracyte seller in Q3 2016 was Clough Capital Partners, an estimated $1.35M sold.
Based on aggregated 13F filings for Q3 2016.